138 related articles for article (PubMed ID: 30818930)
21. [Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
[No Abstract] [Full Text] [Related]
22. [Clinical Efficacy and Prognostic Factors of Newly Diagnosed Children[JP] with Burkitt Lymphoma Treated by High-Dose and Short-Course Modified LMB Regimen ± Rituximab].
Wang BT; Dang HB; Wei YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):529-534. PubMed ID: 32319391
[TBL] [Abstract][Full Text] [Related]
23. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.
Alwan F; He A; Montoto S; Kassam S; Mee M; Burns F; Edwards S; Wilson A; Tenant-Flowers M; Marcus R; Ardeshna KM; Bower M; Cwynarski K
AIDS; 2015 May; 29(8):903-10. PubMed ID: 25730506
[TBL] [Abstract][Full Text] [Related]
24. Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma.
Umeda K; Fujino H; Saida S; Kato I; Hiramatsu H; Yamada T; Hori T; Adachi S; Heike T; Watanabe K
Pediatr Int; 2015 Apr; 57(2):e30-3. PubMed ID: 25868956
[TBL] [Abstract][Full Text] [Related]
25. [Curative effect analysis of rituximab combined with intensive chemotherapy for follicular lymphoma patients with bone marrow involvement].
Xiong W; Yi S; Li H; Liu H; Li Z; Lü R; Liu W; Zou D; Qiu L
Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3593-7. PubMed ID: 26813371
[TBL] [Abstract][Full Text] [Related]
26. [Intensive chemotherapy in Burkitt's lymphoma and aggressive non-Hodgkin's lymphoma].
Holte H; Smeland S; Blystad AK; Kvaløy S; Hammerstrøm J; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2002 Feb; 122(4):364-9. PubMed ID: 11915663
[TBL] [Abstract][Full Text] [Related]
27. [Long term efficacy of COPADM regimen in the treatment of 20 patients with Burkitt lymphoma].
Yang D; Wang P; Chen J; Li CX; Zhang Y; Chen XC; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):645-649. PubMed ID: 30180465
[No Abstract] [Full Text] [Related]
28. Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma.
Li Y; Huang S; Wang X; Zhou D; Huang K; Guo H; Fang J; Chen C; Liu Q
J Trop Pediatr; 2010 Oct; 56(5):337-41. PubMed ID: 20065046
[TBL] [Abstract][Full Text] [Related]
29. The BFM-protocol for HIV-negative Burkitt's lymphomas and L3 ALL in adult patients: a high chance for cure.
Pees HW; Radtke H; Schwamborn J; Graf N
Ann Hematol; 1992 Nov; 65(5):201-5. PubMed ID: 1457577
[TBL] [Abstract][Full Text] [Related]
30. Rituximab and reduced-intensity chemotherapy in children and adolescents with mature B-cell lymphoma: interim results for 231 patients enrolled in the second Russian-Belorussian multicentre study B-NHL-2010M.
Maschan A; Myakova N; Aleinikova O; Abugova Y; Ponomareva N; Belogurova M; Fechina L; Fedorova A; Grigor'eva N; Lebedev V; Nikonova O; Shamardina A; Sharapova G; Smirnova N; Rudneva A; Volchkov E; Samochatova E
Br J Haematol; 2019 Aug; 186(3):477-483. PubMed ID: 31069789
[TBL] [Abstract][Full Text] [Related]
31. Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).
Ribera JM; García O; Grande C; Esteve J; Oriol A; Bergua J; González-Campos J; Vall-Llovera F; Tormo M; Hernández-Rivas JM; García D; Brunet S; Alonso N; Barba P; Miralles P; Llorente A; Montesinos P; Moreno MJ; Hernández-Rivas JÁ; Bernal T
Cancer; 2013 May; 119(9):1660-8. PubMed ID: 23361927
[TBL] [Abstract][Full Text] [Related]
32. [Primary lymphomas of bones and soft tissues: comparative assessment of treatment results].
Morozova AK; Zvonkov EE; Mamonov VE; Kremenetskaia AM; Kravchenko SK; Tseĭtlina MA; Stroiakovskiĭ DL; Bapiakh EA; Magomedova AU; Obukhova TN; Kaplanov KD; Pustovoĭt LA; Lukina AI; Gemdzhian ÉG; Egorova EK; Pen'kov MIu; Vorob'ev AI
Ter Arkh; 2012; 84(7):42-9. PubMed ID: 23038971
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens.
Smeland S; Blystad AK; Kvaløy SO; Ikonomou IM; Delabie J; Kvalheim G; Hammerstrøm J; Lauritzsen GF; Holte H
Ann Oncol; 2004 Jul; 15(7):1072-8. PubMed ID: 15205201
[TBL] [Abstract][Full Text] [Related]
34. [Outcomes of modified NHL-BFM-90 protocol for children and adolescents with lymphoblastic lymphoma].
Sun X; Zhen Z; Zhu J; Wang J; Lu S; Xia Y; Sun F; Chen Y; Zhang F; Cai R; Li P; Guo X
Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1083-9. PubMed ID: 25543702
[TBL] [Abstract][Full Text] [Related]
35. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
36. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
37. [Clinical characteristics and treatment strategies for early-stage primary gastric diffuse large B-cell lymphoma].
Qin Y; Liu P; Yang JL; Jin J; He XH; Wang WH; Fang H; Zhou SY; Zhou LQ; Song YW; Shi YK
Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(24):1945-1950. PubMed ID: 29996288
[No Abstract] [Full Text] [Related]
38. Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphoma.
Pohlen M; Gerth HU; Liersch R; Koschmieder S; Mesters RM; Kessler T; Appelmann I; Müller-Tidow C; Berdel WE
Am J Hematol; 2011 Dec; 86(12):E61-4. PubMed ID: 21898532
[TBL] [Abstract][Full Text] [Related]
39. [The clinical characteristics and outcomes of 16 Burkitt' s lymphoma with testicular involvement].
Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):768-773. PubMed ID: 27719719
[TBL] [Abstract][Full Text] [Related]
40. [Rituximab combined with short-course and intensive regimen for Burkitt leukemia: efficacy and safety analysis].
Li Y; Gong XY; Zhao XL; Wei H; Wang Y; Lin D; Zhou CL; Liu BC; Wang HJ; Li CW; Li QH; Gong BF; Liu YT; Wei SN; Zhang GJ; Mi YC; Wang JX; Liu KQ
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):502-505. PubMed ID: 32654465
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
